We are live on ! Find out more
FLAM

First Light Asset Management Portfolio holdings

AUM $1.12B
1-Year Est. Return 114.45%
This Fund
S&P 500
This Quarter Est. Return
+13.71%
1 Year Est. Return
+114.45%
3 Year Est. Return
+266.49%
5 Year Est. Return
+454.92%
10 Year Est. Return
+8,470.94%
AUM
$1.67B
AUM Growth
+$159M
Cap. Flow
+$11.7M
Cap. Flow %
0.7%
Top 10 Hldgs %
44.6%
Holding
84
New
7
Increased
30
Reduced
18
Closed
5

Top Sells

Rank Stock Value
1
PRTA icon
Prothena Corp
PRTA
+$31.4M
2
CDNA icon
CareDx
CDNA
+$25.2M
3
BTAI icon
BioXcel Therapeutics
BTAI
+$15.5M
4
MRVI icon
Maravai LifeSciences
MRVI
+$11.2M
5
HCAT icon
Health Catalyst
HCAT
+$11.1M

Sector Composition

Rank Sector Weight
1 Healthcare 83.7%
2 Communication Services 4.44%
3 Energy 0.19%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
FATE icon
51
Fate Therapeutics
FATE
$286M
$1.34M 0.08%
+15,400
New +$1.24M
ITGR icon
52
Integer Holdings
ITGR
$4.12B
$551K 0.03%
5,846
NUVA
53
DELISTED
NuVasive, Inc.
NUVA
$532K 0.03%
7,850
WAT icon
54
Waters Corp
WAT
$37B
$531K 0.03%
1,536
AVTR icon
55
Avantor
AVTR
$9.32B
$518K 0.03%
14,596
SYNH
56
DELISTED
Syneos Health, Inc. Class A Common Stock
SYNH
$513K 0.03%
5,736
NVST icon
57
Envista
NVST
$4.44B
$510K 0.03%
11,793
GSK icon
58
GSK
GSK
$104B
$501K 0.03%
10,059
HRC
59
DELISTED
HILL-ROM HOLDINGS, INC.
HRC
$494K 0.03%
4,346
BMY icon
60
Bristol-Myers Squibb
BMY
$133B
$485K 0.03%
7,256
BAX icon
61
Baxter International
BAX
$13.5B
$477K 0.03%
5,929
ELV icon
62
Elevance Health
ELV
$81.5B
$475K 0.03%
1,244
HUM icon
63
Humana
HUM
$43.7B
$473K 0.03%
+1,068
New +$467K
GILD icon
64
Gilead Sciences
GILD
$162B
$462K 0.03%
6,705
CI icon
65
Cigna
CI
$73.7B
$461K 0.03%
1,943
CVS icon
66
CVS Health
CVS
$133B
$461K 0.03%
5,519
BDX icon
67
Becton Dickinson
BDX
$45.6B
$459K 0.03%
1,935
+231
+14% +$55.4K
PRGO icon
68
Perrigo
PRGO
$1.4B
$450K 0.03%
9,823
UTHR icon
69
United Therapeutics
UTHR
$25.8B
$442K 0.03%
2,466
TAK icon
70
Takeda Pharmaceutical
TAK
$54.6B
$431K 0.03%
+25,630
New +$436K
ABBV icon
71
AbbVie
ABBV
$443B
$421K 0.03%
3,740
-2,241
-37% -$252K
ICUI icon
72
ICU Medical
ICUI
$4.21B
$420K 0.03%
2,039
HOLX
73
DELISTED
Hologic
HOLX
$390K 0.02%
5,845
JNJ icon
74
Johnson & Johnson
JNJ
$618B
$356K 0.02%
2,161
SNY icon
75
Sanofi
SNY
$103B
$350K 0.02%
6,650

Similar funds

First Light Asset Management's Q2 2021 Portfolio in Review

As of Q2 2021, First Light Asset Management held 84 positions worth $1.67B, up 11% from $1.51B the previous quarter. Its ten largest holdings account for 45% of the portfolio.

First Light Asset Management's Q2 2021 filing shows 7 new, 30 increased, 18 reduced and 5 closed positions. Its largest new stake was Relay Therapeutics: 390,555 shares worth $14.3M. The largest sale was Prothena Corp, an estimated $31.4M.

By sector, the portfolio is most concentrated in Healthcare at 84% of assets, down from 84% a quarter earlier, followed by Communication Services and Energy.

  • First Light Asset Management's largest Q2 2021 buy was Relay Therapeutics: 390,555 shares worth $14.3M.
  • First Light Asset Management added most to Turning Point Therapeutics, Inc. Common Stock in Q2 2021, an estimated $24.9M increase.
  • First Light Asset Management's biggest Q2 2021 reduction was Prothena Corp, cutting an estimated $31.4M.
  • First Light Asset Management fully exited BioXcel Therapeutics in Q2 2021, selling an estimated $15.5M.
  • First Light Asset Management's ten largest holdings make up 45% of its $1.67B portfolio in Q2 2021.
  • First Light Asset Management opened 7 new positions and closed 5 in Q2 2021.
  • First Light Asset Management's portfolio value rose 11% quarter-over-quarter to $1.67B.

Based on First Light Asset Management's 13F filing for Q2 2021, filed 13 Aug 2021.